This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
L01XE Protein kinase inhibitors
RX_L01XE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2002 |
4. Check minimum number of events
Min. number of events
3
|
2002 |
5. Include endpointsNone |
2002 |
6. Filter based on genotype QC (FinnGen only) |
2002 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
L01XE Protein kinase inhibitors
based on the number of shared cases.
Similar with more cases:
- Any reimbursement code in KELA
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2002 | 1050 | 952 |
| Unadjusted period prevalence (%) | 0.39 | 0.36 | 0.42 |
| Median age at first event (years) | 67.36 | 65.94 | 68.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1896
- Matched controls
- 18961
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
22.8
323.0
991
869
WF049
NOMESCO Finland
Radiotherapy of metastasis
27.4
323.0
539
271
JN4BD
NOMESCO Finland
Extensive body CT
12.2
323.0
904
1313
L01XE33
ATC
[U] palbociclib; oral
561.7
323.0
328
7
N02AA05
ATC
oxycodone; systemic
8.4
323.0
867
1719
1501
Kela drug reimbursment
Palbociclib
220.8
323.0
329
18
A03FA01
ATC
metoclopramide; systemic, rectal
10.5
323.0
1177
2557
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
220.8
323.0
572
37
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
33.5
323.0
619
270
H02AB02
ATC
dexamethasone; systemic
9.9
317.2
731
1128
189
Kela drug reimbursment
Imatinib
1716.9
305.6
289
*
Z51.5
ICD-10 Finland
Palliative care
13.6
303.5
568
577
L01XE01
ATC
[U] imatinib; oral
+∞
302.4
282
*
197
Kela drug reimbursment
Sunitinib
426.1
298.6
292
8
L01XE04
ATC
[U] sunitinib; oral
1050.9
283.8
271
*
394
Kela drug reimbursment
Palbociclib
204.1
273.6
279
16
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
25.3
240.6
346
166
JN4AD
NOMESCO Finland
Body CT examination
8.9
235.0
560
854
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.7
233.2
413
352
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
21.0
197.4
301
169
A04AA02
ATC
granisetron; systemic, transdermal
9.0
194.2
448
627
L01XE31
ATC
[U] nintedanib; oral
+∞
194.2
183
*
M05BX04
ATC
denosumab; parenteral
10.2
189.2
404
492
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.3
187.4
1061
4344
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
28.7
178.4
246
98
A04AA01
ATC
ondansetron; systemic, rectal
8.3
176.4
430
650
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.6
173.7
359
407
284
Kela drug reimbursment
Nintedanib and pirfenidone
135.7
173.7
184
15
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
236.2
169.2
172
8
L01EF01
ATC
palbociclib; oral
169.6
163.4
170
11
L02BA03
ATC
fulvestrant; parenteral
80.7
163.0
183
25
JN4CD
NOMESCO Finland
Very extensive body CT
10.0
159.3
339
402
159
Kela drug reimbursment
Pazopanib
289.3
158.1
159
6
192
Kela drug reimbursment
Fulvestrant
78.5
152.6
172
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
151.6
1257
6641
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
70.3
151.1
173
27
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
29.0
146.5
201
77
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
129.7
145.5
155
13
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
1497.9
143.6
138
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
41.9
137.0
172
45
115
Kela drug reimbursment
Breast cancer
6.0
135.2
419
859
356
Kela drug reimbursment
Nintedanib and pirfenidone
140.4
135.2
143
11
L01XE11
ATC
[U] pazopanib; oral
473.5
134.9
133
*
WZC30
NOMESCO Finland
Teaching
4.6
134.4
560
1596
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
25.3
133.3
190
83
158
Kela drug reimbursment
Everolimus
+∞
132.9
126
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
38.0
132.6
170
49
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.4
130.6
307
424
1502
Kela drug reimbursment
Cabozantinib
454.3
129.6
128
*
L02BG04
ATC
letrozole; oral
7.2
129.4
342
564
198
Kela drug reimbursment
Sorafenib
177.1
127.1
132
8
316
Kela drug reimbursment
Imatinib
1278.9
124.4
120
*
WF004
NOMESCO Finland
Palliative radiotherapy
15.4
123.0
209
151
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
122.6
465
1189
3012
Kela drug reimbursment
Cabozantinib
427.4
122.2
121
*
L01XE05
ATC
[U] sorafenib; oral
328.3
121.8
122
*
L03AA02
ATC
filgrastim; parenteral
12.8
121.5
225
198
WW500
NOMESCO Finland
Blood transfusion
9.4
120.1
263
320
L01BC06
ATC
capecitabine; oral
8.9
118.4
268
345
L01XE26
ATC
[U] cabozantinib; oral
1176.9
114.9
111
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
13.5
113.8
205
169
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.5
111.9
315
560
L01XE23
ATC
[U] dabrafenib; oral
+∞
111.6
106
*
XW000
NOMESCO Finland
Bone marrow biopsy
8.3
110.7
262
361
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
1131.9
110.6
107
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
29.5
110.1
150
55
155
Kela drug reimbursment
Afatinib and gefitinib
564.3
108.9
107
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
14.5
108.0
188
143
ZX120
NOMESCO Finland
Intravenous
4.9
107.8
402
996
L01CA04
ATC
vinorelbine; systemic
32.8
105.6
140
46
322
Kela drug reimbursment
Sunitinib
541.8
104.7
103
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
8.3
103.0
242
328
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.1
100.6
240
333
191
Kela drug reimbursment
Erlotinib
217.6
100.5
103
5
L02BA01
ATC
tamoxifen; oral
7.9
99.2
240
340
L03AA13
ATC
pegfilgrastim; parenteral
7.8
98.4
241
348
L02BG06
ATC
exemestane; oral
18.5
97.8
154
90
L01XE10
ATC
[U] everolimus; oral
+∞
97.7
93
*
L01EX09
ATC
nintedanib; oral
260.9
97.6
99
*
L01XE03
ATC
[U] erlotinib; oral
208.7
96.3
99
5
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
95.6
91
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
95.6
91
*
R50.9
ICD-10 Finland
Fever, unspecified
3.8
95.2
475
1532
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
26.5
92.1
129
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
91.1
468
1540
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.4
89.6
292
614
390
Kela drug reimbursment
Ibrutinib
238.7
89.3
91
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
9.7
88.6
188
213
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
25.9
88.0
124
51
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
309.4
87.5
88
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
85.5
878
4610
XX3DW
NOMESCO Finland
Time consuming IT work
3.9
84.0
396
1202
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
82.1
332
873
L01XE25
ATC
[U] trametinib; oral
+∞
81.9
78
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
9.2
81.3
177
209
HAC20
NOMESCO Finland
Total mastectomy
6.5
80.7
223
379
B01AB05
ATC
enoxaparin; parenteral
2.6
80.4
829
4313
1512
Kela drug reimbursment
Ibrutinib
214.1
79.9
82
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
22.6
79.8
117
55
A02BC02
ATC
pantoprazole; systemic
2.7
79.1
1442
10253
X76
ICPC
Malignant neoplasm breast female
10.4
78.1
159
166
L01XE13
ATC
[U] afatinib; oral
757.0
74.7
73
*
B01AB10
ATC
tinzaparin; parenteral
4.4
74.6
295
754
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
73.5
365
1146
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
23.8
72.2
104
46
NK6AN
NOMESCO Finland
Total body bone isotope imaging
6.6
72.2
196
324
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
72.0
252
567
HA1AA
NOMESCO Finland
X-ray mammography
4.4
71.9
287
739
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
13.7
71.8
127
99
168
Kela drug reimbursment
Axitinib
713.8
70.5
69
*
176
Kela drug reimbursment
Regorafenib
89.2
69.5
77
9
L01XE18
ATC
[U] ruxolitinib; oral
+∞
69.2
66
*
L04AX05
ATC
pirfenidone; oral
80.3
68.6
77
10
174
Kela drug reimbursment
Ruxolitinib
+∞
67.1
64
*
340
Kela drug reimbursment
Everolimus
+∞
67.1
64
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.6
64.7
137
153
A79
ICPC
Malignancy NOS
12.9
64.6
117
96
L01EX07
ATC
cabozantinib; oral
649.4
64.2
63
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
63.4
309
946
L01XE21
ATC
[U] regorafenib; oral
90.8
63.3
70
8
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
13.1
62.9
113
91
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
62.6
688
3577
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
323.2
61.7
62
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
61.6
600
2919
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
61.0
222
517
152
Kela drug reimbursment
Nilotinib
+∞
60.7
58
*
150
Kela drug reimbursment
Dasatinib
+∞
60.7
58
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.2
58.7
166
288
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.3
58.0
163
280
C03CA01
ATC
furosemide; systemic
2.4
57.8
692
3723
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
202.8
57.3
59
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
202.8
57.3
59
*
L01XX05
ATC
hydroxycarbamide; oral
12.0
57.2
107
94
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
8.1
56.7
132
173
L01XE06
ATC
[U] dasatinib; systemic
+∞
56.5
54
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.3
56.3
157
267
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.3
56.0
129
166
L01XE17
ATC
[U] axitinib; oral
+∞
55.5
53
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
52.5
55.3
66
13
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
4.2
55.2
230
610
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
54.4
256
755
374
Kela drug reimbursment
Ruxolitinib
+∞
54.4
52
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
19.7
54.4
83
44
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
13.8
54.3
95
72
L01XE07
ATC
[U] lapatinib; oral
+∞
53.4
51
*
A04AD12
ATC
aprepitant; systemic
8.1
53.3
124
162
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
4.6
52.6
194
456
L01EL01
ATC
ibrutinib; oral
273.2
52.4
53
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
52.3
534
2622
1CD02
NOMESCO Finland
NA
17.3
52.0
83
50
A06AH03
ATC
naloxegol; oral
11.7
50.8
96
86
369
Kela drug reimbursment
Regorafenib
60.8
50.7
59
10
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
8.7
50.1
111
134
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.2
49.7
202
521
L01XX28
ATC
[D] imatinib; oral
+∞
49.2
47
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
11.2
48.7
94
88
156
Kela drug reimbursment
Lapatinib
251.3
48.2
49
*
L01EJ01
ATC
ruxolitinib; oral
+∞
48.1
46
*
E0000UV
ATC
NA
2.1
48.1
826
5117
C50.99
ICD-10 Finland
Breast, unspecified
6.3
47.7
133
226
H02AB06
ATC
prednisolone; systemic
2.0
47.3
1005
6773
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
10.4
46.9
94
95
J01MA12
ATC
levofloxacin; systemic
2.4
46.8
495
2453
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
46.5
243
776
180
Kela drug reimbursment
Interferon alfa
39.9
46.2
58
15
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
23.5
46.0
66
29
M04AA01
ATC
allopurinol; systemic
2.7
45.8
372
1594
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.5
45.7
111
155
341
Kela drug reimbursment
Afatinib and gefitinib
458.3
45.4
45
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
26.0
45.2
63
25
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
25.6
44.3
62
25
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.8
44.3
73
48
343
Kela drug reimbursment
Pazopanib
120.4
43.9
47
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.3
43.0
107
155
TGC00
NOMESCO Finland
Bronchial lavation
5.5
42.9
132
253
L01XE08
ATC
[U] nilotinib; oral
+∞
42.9
41
*
J94.8
ICD-10 Finland
Other specified pleural conditions
7.9
41.7
98
130
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
7.1
41.7
105
155
U75
ICPC
Malignant neoplasm of kidney
55.8
41.6
49
9
L01XE02
ATC
[U] gefitinib; oral
416.3
41.3
41
*
L01EX01
ATC
sunitinib; oral
416.3
41.3
41
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
78.6
41.0
46
6
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.2
40.5
131
266
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.8
40.1
75
66
J01MA14
ATC
moxifloxacin; systemic
3.0
40.1
258
950
A04AA55
ATC
palonosetron, combinations; systemic
5.6
39.0
118
222
323
Kela drug reimbursment
Sorafenib
88.0
38.9
43
5
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.3
38.7
124
249
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
34.2
38.6
50
15
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.3
38.2
121
240
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
38.0
305
1286
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
8.9
37.7
82
96
PJA12
NOMESCO Finland
Sentinel node biopsy
3.1
37.7
232
828
361
Kela drug reimbursment
Axitinib
+∞
37.6
36
*
L03AB05
ATC
interferon alfa-2b; parenteral
27.5
37.3
51
19
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.1
37.2
64
47
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
36.9
391
1910
R4110
NOMESCO Finland
Physiotherapy
2.0
36.7
599
3532
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
23.2
36.3
52
23
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.1
36.3
83
106
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
11.7
35.9
67
59
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.6
35.9
109
206
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
+∞
35.5
34
*
ZX112
NOMESCO Finland
Subcutaneous
6.2
35.2
98
166
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
17.7
35.0
55
32
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
11.6
34.6
65
58
B01AB04
ATC
dalteparin; parenteral
3.5
34.3
171
522
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
14.6
34.3
58
41
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.4
34.3
60
46
JN6AD
NOMESCO Finland
CT of torso and neck
9.3
34.2
72
80
324
Kela drug reimbursment
Dasatinib
+∞
33.4
32
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.5
33.3
123
288
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.3
32.9
90
149
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.4
32.3
100
193
3004
Kela drug reimbursment
Osimertinib
322.2
31.9
32
*
ZX080
NOMESCO Finland
Image guided radiotherapy
6.0
31.6
90
157
N02BE01
ATC
paracetamol; systemic, rectal
2.2
31.2
1658
14452
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
11.7
31.2
58
51
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
31.1
191
677
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
43.0
30.9
38
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.4
30.4
156
487
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
38.8
30.3
38
10
328
Kela drug reimbursment
Nilotinib
+∞
30.3
29
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
33.1
30.0
39
12
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.3
30.0
162
526
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
29.9
163
533
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
29.1
29.9
40
14
L02BG03
ATC
anastrozole; oral
6.4
29.4
79
128
L01EA03
ATC
nilotinib; oral
+∞
29.2
28
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
28.9
181
651
A06AD11
ATC
lactulose; oral
2.2
28.7
322
1596
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
11.6
28.4
53
47
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
28.3
454
2613
B03XA02
ATC
darbepoetin alfa; parenteral
6.0
28.3
80
139
L03AA14
ATC
lipegfilgrastim; parenteral
6.8
28.2
72
109
L01EA02
ATC
dasatinib; oral
+∞
28.2
27
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
10.5
28.0
55
54
R4190
NOMESCO Finland
Nutritional therapy
4.3
28.0
108
264
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
14.6
28.0
47
33
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
28.0
332
1686
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.8
27.9
188
709
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
27.7
214
874
R84
ICPC
Malignant neoplasm bronchus/lung
18.6
27.5
42
23
3001
Kela drug reimbursment
Alectinib
+∞
27.1
26
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
8.5
27.1
60
73
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.4
27.0
100
235
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
27.0
181
678
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
5.0
26.7
87
179
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
26.6
141
451
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.3
26.5
138
436
1504
Kela drug reimbursment
Alectinib
+∞
26.1
25
*
N02AA01
ATC
morphine; systemic, rectal
7.8
25.9
60
79
169
Kela drug reimbursment
Crizotinib
264.0
25.7
26
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
136.9
25.7
27
*
Z31.5
ICD-10 Finland
Genetic counselling
3.7
25.4
114
320
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.8
25.2
42
29
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
25.0
733
5117
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
6.0
24.7
69
118
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
32.5
24.7
32
10
1519
Kela drug reimbursment
NA
131.7
24.6
26
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.7
24.5
85
187
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
27.9
24.5
33
12
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
15.1
24.3
40
27
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
4.9
24.2
81
172
L01XE36
ATC
[U] alectinib; oral
+∞
24.0
23
*
L01EB03
ATC
afatinib; oral
+∞
24.0
23
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.6
24.0
62
96
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
11.5
23.7
44
39
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
5.5
23.7
71
133
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
42.0
23.6
29
7
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
9.0
23.6
50
57
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
6.0
23.4
65
111
JDA63
NOMESCO Finland
Local excision of lesion of stomach
47.3
23.3
28
6
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
16.4
23.2
37
23
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
11.5
23.2
43
38
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
11.6
22.7
42
37
1513
Kela drug reimbursment
Binimetinib and encorafenib
84.5
22.7
25
*
L01XE16
ATC
[U] crizotinib; oral
232.6
22.7
23
*
L01EC02
ATC
dabrafenib; oral
121.5
22.6
24
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
22.6
919
6957
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
22.5
159
614
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
22.4
126
419
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
6.9
22.4
56
83
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
7.3
22.4
54
76
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.1
22.3
61
102
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
5.0
22.2
72
148
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
24.2
22.2
31
13
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.8
22.0
56
85
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
17.3
21.8
34
20
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.4
21.8
52
72
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
25.4
21.8
30
12
L01EB04
ATC
osimertinib; oral
222.4
21.6
22
*
J01DB01
ATC
cefalexin; oral
1.7
21.4
1519
13237
Z2446
NOMESCO Finland
Social worker
2.8
21.4
145
545
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.0
21.4
69
141
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.2
21.1
113
365
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
+∞
20.9
20
*
L01ED03
ATC
alectinib; oral
+∞
20.9
20
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
12.6
20.9
37
30
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.4
20.8
55
88
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
20.8
91
250
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
20.6
507
3316
L01XE35
ATC
[U] osimertinib; oral
212.2
20.6
21
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
30.4
20.6
27
9
L01BC59
ATC
trifluridine, combinations; systemic
30.4
20.6
27
9
TQW20
NOMESCO Finland
Tatoe
6.7
20.3
52
80
FM1FN
NOMESCO Finland
Heart function isotope examination
11.1
20.2
38
35
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
19.0
20.0
30
16
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.0
19.9
81
209
L01XE15
ATC
[U] vemurafenib; oral
+∞
19.8
19
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
19.8
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
19.8
238
1205
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
7.1
19.7
48
69
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
9.9
19.6
39
40
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
19.6
222
1096
SPAT1255
SPAT
Intravenous administration of medicine
2.5
19.6
156
647
N03AX14
ATC
levetiracetam; systemic
4.1
19.5
77
194
R18
ICD-10 Finland
Ascites
4.7
19.4
66
143
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.0
19.4
114
393
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
7.7
19.4
45
60
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
8.9
19.4
41
47
R11
ICD-10 Finland
Nausea and vomiting
2.4
19.2
168
733
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
20.3
19.1
28
14
N05CF01
ATC
zopiclone; oral
1.6
18.9
605
4240
B73
ICPC
Leukaemia
34.7
18.9
24
7
A28
ICPC
Limited function/disability NOS
1.9
18.9
306
1741
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.1
18.8
51
85
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.7
18.7
40
47
WX892
NOMESCO Finland
Monitored bed care
2.3
18.6
187
871
L01EE01
ATC
trametinib; oral
191.8
18.6
19
*
399
Kela drug reimbursment
Venetoclax
191.8
18.6
19
*
335
Kela drug reimbursment
Lapatinib
191.8
18.6
19
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
10.8
18.4
35
33
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
4.9
18.4
60
125
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.9
18.3
77
205
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
18.3
131
509
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
17.7
18.2
28
16
KAC00
NOMESCO Finland
Nephrectomy
21.9
18.2
26
12
ZXA00
NOMESCO Finland
Right side
1.6
18.2
534
3653
ZXE00
NOMESCO Finland
One hour or less
1.6
18.1
722
5334
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
18.1
564
3917
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.5
18.1
30
21
WF002
NOMESCO Finland
Radical radiotherapy
2.6
17.9
137
556
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
5.4
17.9
54
103
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
9.6
17.9
36
38
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.0
17.8
57
116
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
17.8
122
464
L01AX03
ATC
temozolomide; systemic
12.0
17.8
32
27
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.2
17.8
55
108
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
7.4
17.8
42
58
N02AX02
ATC
tramadol; systemic, rectal
1.5
17.7
806
6139
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
9.0
17.7
37
42
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
17.7
183
864
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
12.6
17.6
31
25
3019
Kela drug reimbursment
Lenvatinib
95.9
17.6
19
*
L01XX52
ATC
venetoclax; oral
181.6
17.5
18
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.2
17.4
47
78
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.8
17.4
49
86
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
4.0
17.2
70
182
1XC07
NOMESCO Finland
NA
22.1
16.9
24
11
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
22.1
16.9
24
11
ZX121
NOMESCO Finland
Central venous catheter
22.1
16.9
24
11
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.9
16.8
106
382
Z3231
NOMESCO Finland
Registered nurse
1.6
16.7
534
3720
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.4
16.6
80
239
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.2
16.6
64
158
1508
Kela drug reimbursment
Lenvatinib
90.9
16.6
18
*
L01EK01
ATC
axitinib; oral
171.4
16.5
17
*
8936/3-C16.9
ICD-O-3
Gastrointestinal stromal tumor of stomach, NOS
171.4
16.5
17
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
16.4
333
2036
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
40.4
16.3
20
5
H03AA01
ATC
levothyroxine sodium; systemic
1.7
16.3
433
2864
JFB00
NOMESCO Finland
Partial resection of small intestine
5.1
16.3
51
102
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
10.5
16.2
31
30
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
9.3
16.2
33
36
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
7.1
16.1
39
56
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
30.3
16.1
21
7
N03AX16
ATC
pregabalin; oral
1.6
16.0
447
2998
C64.80
ICD-10 Finland
Wilms tumour
18.7
16.0
24
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
16.0
725
5477
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
5.4
15.9
47
88
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
60.5
15.8
18
*
L01BB05
ATC
fludarabine; systemic
15.8
15.7
25
16
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
15.7
119
481
L01XX47
ATC
[U] idelalisib; oral
+∞
15.6
15
*
L01XE41
ATC
[U] binimetinib; oral
+∞
15.6
15
*
L01XE46
ATC
[U] encorafenib; oral
+∞
15.6
15
*
L02AE03
ATC
goserelin; implant
5.9
15.6
43
74
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
85.8
15.6
17
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
22.2
15.5
22
10
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
13.9
15.5
26
19
372
Kela drug reimbursment
Idelalisib
161.2
15.5
16
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
15.4
136
596
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
15.3
437
2944
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
8.8
15.2
32
37
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
9.2
15.2
31
34
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
20.2
15.1
22
11
NF3AA
NOMESCO Finland
Femur X-ray examination
4.2
15.1
57
139
N05BA06
ATC
lorazepam; systemic, sublingual
2.5
15.1
116
473
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
45.4
15.1
18
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
11.9
15.1
27
23
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
5.3
15.0
45
86
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
4.9
15.0
48
99
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
9.5
14.9
30
32
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
5.3
14.9
45
87
D45
ICD-10 Finland
Polycythaemia vera
5.9
14.8
41
71
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
14.8
234
1313
L01EX02
ATC
sorafenib; oral
57.1
14.8
17
*
5BA08
NOMESCO Finland
NA
9.8
14.7
29
30
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.5
14.6
51
115
H02AB09
ATC
hydrocortisone; systemic
4.0
14.6
58
148
8936/1-C17.9
ICD-O-3
Gastrointestinal stromal tumor, NOS, of small intestine, NOS
+∞
14.6
14
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
14.3
14.5
24
17
1XC14
NOMESCO Finland
NA
151.1
14.5
15
*
1518
Kela drug reimbursment
NA
151.1
14.5
15
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
9.5
14.4
29
31
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
36.3
14.4
18
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
14.4
191
1005
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
12.6
14.4
25
20
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
11.4
14.3
26
23
L03AB04
ATC
interferon alfa-2a; parenteral
19.3
14.2
21
11
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.9
14.2
88
316
Z3226
NOMESCO Finland
Physiotherapist
1.7
14.1
351
2270
1BA04
NOMESCO Finland
NA
42.8
14.1
17
*
AA1AD
NOMESCO Finland
CT of head and brain
1.6
14.1
459
3189
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
14.1
710
5449
1XC03
NOMESCO Finland
NA
14.5
14.1
23
16
127
Kela drug reimbursment
Transplant complication
4.9
14.0
45
93
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.0
13.9
80
273
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
12.8
13.9
24
19
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.1
13.8
43
86
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
4.1
13.8
53
132
D07AA02
ATC
hydrocortisone; topical
1.9
13.7
225
1278
ZX100
NOMESCO Finland
Oral
4.7
13.7
46
100
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
13.7
781
6141
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
12.1
13.6
24
20
1515
Kela drug reimbursment
NA
75.7
13.6
15
*
3030
Kela drug reimbursment
Abemaciclib
75.7
13.6
15
*
170
Kela drug reimbursment
Bosutinib
+∞
13.6
13
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
13.5
128
581
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
13.4
161
813
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.6
13.4
96
377
C50
ICD-10 Finland
Malignant neoplasm of breast
3.4
13.3
65
198
212
Kela drug reimbursment
Gout
3.5
13.3
61
177
N05BA04
ATC
oxazepam; oral
1.6
13.3
418
2873
TGA30
NOMESCO Finland
Thoracocentesis
6.4
13.2
34
54
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
40.4
13.2
16
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
40.4
13.2
16
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
8.8
13.0
27
31
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
28.6
13.0
17
6
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
28.6
13.0
17
6
5BX04
NOMESCO Finland
NA
22.7
12.9
18
8
J05AB11
ATC
valaciclovir; oral
1.8
12.8
238
1408
R06.0
ICD-10 Finland
Dyspnoea
1.5
12.8
453
3201
TQB05
NOMESCO Finland
Puncture of skin of trunk
7.2
12.8
30
42
ZXA05
NOMESCO Finland
Left side
1.5
12.8
475
3392
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.7
12.7
42
90
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
9.7
12.7
25
26
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
9.7
12.7
25
26
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
70.3
12.6
14
*
L01EF03
ATC
abemaciclib; oral
70.3
12.6
14
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.3
12.5
27
33
ZXD05
NOMESCO Finland
Urgent procedure
1.5
12.5
525
3849
J01CA04
ATC
amoxicillin; systemic
1.5
12.5
1404
12490
WW200
NOMESCO Finland
Immunization
3.1
12.5
67
219
L01XE14
ATC
[U] bosutinib; oral
+∞
12.5
12
*
8936/3-C17.9
ICD-O-3
Gastrointestinal stromal tumor of small intestine, NOS
+∞
12.5
12
*
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
12.5
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
12.5
296
1884
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
10.1
12.5
24
24
8936/1-C16.9
ICD-O-3
Gastrointestinal stromal tumor, NOS, of stomach, NOS
24.5
12.5
17
7
363
Kela drug reimbursment
Crizotinib
130.8
12.4
13
*
325
Kela drug reimbursment
Erlotinib
130.8
12.4
13
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.0
12.2
38
77
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
4.0
12.2
48
123
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
4.2
12.1
45
109
WX110
NOMESCO Finland
Local anesthesy
1.4
12.1
1180
10178
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
12.0
133
649
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.7
12.0
52
145
L01EX03
ATC
pazopanib; oral
46.9
11.9
14
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
11.9
336
2243
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
11.8
11.8
21
18
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.7
11.8
33
59
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
5.4
11.6
34
64
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
11.6
128
624
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.1
11.6
63
209
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
+∞
11.5
11
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
11.5
11
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
13.7
11.5
19
14
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
120.7
11.4
12
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.1
11.4
35
70
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
6.1
11.3
30
50
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
11.3
288
1865
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
11.9
11.3
20
17
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
15.1
11.3
18
12
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
35.2
11.3
14
*
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
11.2
111
515
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.9
11.2
67
237
ZZF00
NOMESCO Finland
Graft of adipose tissue
6.0
11.2
30
51
ZX108
NOMESCO Finland
Inhalation
6.8
11.1
27
40
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
25.2
11.1
15
6
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
25.2
11.1
15
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.1
11.1
42
104
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.1
11.1
34
68
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
11.0
104
471
B03XA01
ATC
erythropoietin; parenteral
5.4
11.0
32
60
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
15.6
10.8
17
11
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
15.6
10.8
17
11
C10AA07
ATC
rosuvastatin; oral
0.6
10.7
235
3482
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
28.2
10.7
14
5
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
17.9
10.7
16
9
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
21.6
10.7
15
7
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.6
10.7
36
80
SPAT1088
SPAT
Blood transfusion
7.6
10.7
24
32
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
7.6
10.7
24
32
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
10.6
150
2461
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
60.3
10.6
12
*
A46
ICD-10 Finland
Erysipelas
1.7
10.6
255
1625
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
11.3
10.5
19
17
C95.9
ICD-10 Finland
Leukaemia, unspecified
110.6
10.4
11
*
M907, C6488
ICD-10 Finland
NA
+∞
10.4
10
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
10.4
71
273
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
10.3
107
508
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.3
10.3
30
57
KAD00
NOMESCO Finland
Partial nephrectomy
6.7
10.2
25
38
R06AE07
ATC
cetirizine; oral
1.4
10.2
697
5579
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
13.2
10.2
17
13
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
5.7
10.1
28
50
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
4.3
10.1
36
85
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.9
10.1
24
35
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
10.1
95
432
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
6.5
10.0
25
39
C43
ICD-10 Finland
Malignant melanoma of skin
9.2
10.0
20
22
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
10.0
68
261
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.0
252
1629
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
10.0
622
4891
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
40.3
10.0
12
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
4.1
9.9
37
91
ZZR10
NOMESCO Finland
Flap of skin and muscle
5.1
9.9
30
60
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
4.2
9.9
36
87
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.0
9.8
56
190
1XC13
NOMESCO Finland
NA
26.1
9.8
13
5
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
20.1
9.8
14
7
C83.1
ICD-10 Finland
Mantle cell lymphoma
9.6
9.8
19
20
WX721
NOMESCO Finland
Oxygen concentrator therapy
13.4
9.7
16
12
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
5.8
9.7
26
45
L01EX05
ATC
regorafenib; oral
55.3
9.6
11
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
9.6
78
328
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
11.4
9.6
17
15
SPAT1254
SPAT
Administration of medicine
1.6
9.5
252
1648
ZX114
NOMESCO Finland
Intramuscular
4.0
9.4
36
91
1XC17
NOMESCO Finland
NA
100.5
9.4
10
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
30.2
9.4
12
*
L01ED01
ATC
crizotinib; oral
+∞
9.4
9
*
373
Kela drug reimbursment
Ponatinib
+∞
9.4
9
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
9.4
90
412
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
21.8
9.3
13
6
Z94.2
ICD-10 Finland
Lung transplant status
21.8
9.3
13
6
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
21.8
9.3
13
6
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
9.3
187
1129
D77
ICPC
Malignant digestive neopl other/NOS
8.1
9.3
20
25
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.2
9.3
46
144
J02AC03
ATC
voriconazole; systemic
10.7
9.3
17
16
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
10.7
9.3
17
16
HAB40
NOMESCO Finland
Wedge excision of mammary gland
2.1
9.2
106
527
XX9XW
NOMESCO Finland
NA
5.7
9.2
25
44
A05AA02
ATC
ursodeoxycholic acid; oral
4.0
9.1
35
89
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
7.8
9.1
20
26
WW200
SPAT
NA
0.4
9.1
43
990
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
8.3
9.1
19
23
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
5.4
9.1
26
49
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.0
9.1
49
164
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
4.4
9.0
31
71
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
9.0
75
322
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
15.6
9.0
14
9
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
15.6
9.0
14
9
R83
ICPC
Respiratory infection other
0.6
9.0
133
2162
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
10.7
8.8
16
15
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
8.7
76
334
E83.50
ICD-10 Finland
Hypercalcemia
3.7
8.7
36
98
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
3.2
8.7
43
135
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
5.1
8.6
26
52
JAH00
NOMESCO Finland
Laparotomy
2.7
8.6
55
204
Z2221
NOMESCO Finland
Medical doctor
1.4
8.6
466
3551
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
5.8
8.6
23
40
BCA30
NOMESCO Finland
Unilateral adrenalectomy
16.4
8.5
13
8
TJA10
NOMESCO Finland
Laparocentesis
9.0
8.5
17
19
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
27.6
8.5
11
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
20.1
8.5
12
6
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
20.1
8.5
12
6
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.8
8.4
34
91
1XC02
NOMESCO Finland
NA
4.7
8.4
27
58
3AA13
NOMESCO Finland
NA
12.8
8.4
14
11
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
7.9
8.4
18
23
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
7.9
8.4
18
23
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
7.9
8.4
18
23
C20
ICD-10 Finland
Malignant neoplasm of rectum
6.7
8.4
20
30
S77
ICPC
Malignant neoplasm of skin
4.0
8.3
32
82
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
+∞
8.3
8
*
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
5.3
8.3
24
46
N07BC02
ATC
methadone; systemic
8.6
8.3
17
20
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
7.1
8.2
19
27
L01AA01
ATC
cyclophosphamide; systemic
6.1
8.1
21
35
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
8.1
120
1951
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.5
8.1
36
105
JN4DD
NOMESCO Finland
Scout CT scan of torso
11.7
8.1
14
12
1CD01
NOMESCO Finland
NA
10.1
8.0
15
15
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
5.0
8.0
24
48
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
22.1
8.0
11
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
8.0
90
444
Z51.88
ICD-10 Finland
Other specified medical care
2.9
8.0
46
160
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.6
8.0
34
96
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.2
7.9
39
123
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
6.6
7.9
19
29
SPAT1269
SPAT
Other puncture and/or drainage
4.8
7.8
24
50
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
7.7
294
2087
L01EC03
ATC
encorafenib; oral
45.2
7.7
9
*
L01EX08
ATC
lenvatinib; oral
45.2
7.7
9
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
15.1
7.7
12
8
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
7.7
88
437
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
4.6
7.7
25
55
N05AD01
ATC
haloperidol; systemic
2.6
7.6
54
215
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
18.4
7.6
11
6
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
18.4
7.6
11
6
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
25.1
7.6
10
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
7.6
146
876
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
7.5
78
373
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
6.2
7.5
19
31
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
10.1
7.5
14
14
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
3.5
7.4
32
92
GDB10
NOMESCO Finland
Wedge resection of lung
13.4
7.4
12
9
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
4.6
7.4
24
53
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.1
7.4
27
67
HAD40
NOMESCO Finland
Mastopexy
6.0
7.4
19
32
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
4.4
7.3
25
58
R05
ICD-10 Finland
Cough
1.4
7.3
321
2346
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.4
7.3
33
98
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
8.4
7.3
15
18
WC501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of local recurrence of tumour
+∞
7.3
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
7.3
7
*
L01XE24
ATC
[U] ponatinib; oral
+∞
7.3
7
*
360
Kela drug reimbursment
Bosutinib
+∞
7.3
7
*
8936/3-C17.1
ICD-O-3
Gastrointestinal stromal tumor of jejunum
+∞
7.3
7
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
9.4
7.3
14
15
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
2.7
7.3
47
177
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.3
7.3
61
266
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.2
7.2
21
41
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
15.8
7.2
11
7
1AA09
NOMESCO Finland
NA
15.8
7.2
11
7
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.3
7.2
25
59
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.6
7.2
23
50
8000/3-C64.9
ICD-O-3
Neoplasm, malignant of kidney, NOS
30.1
7.1
9
*
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
4.8
7.1
22
46
ZYC01
SPAT
NA
0.3
7.1
12
438
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
20.1
7.1
10
5
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
20.1
7.1
10
5
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.9
7.1
41
143
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
7.1
102
1674
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
7.9
7.1
15
19
ZX122
NOMESCO Finland
Intra-arterial
7.9
7.1
15
19
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.1
68
316
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
7.1
119
684
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.4
7.1
35
787
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
8.8
7.0
14
16
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
2.6
7.0
49
192
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
10.1
7.0
13
13
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.0
402
3084
Z51.0
ICD-10 Finland
Radiotherapy session
3.5
7.0
30
86
B02AA02
ATC
tranexamic acid; systemic
1.5
7.0
213
1443
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
6.3
6.9
17
27
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
7.5
6.9
15
20
JLC10
NOMESCO Finland
Distal pancreatectomy
7.5
6.9
15
20
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
13.8
6.9
11
8
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
13.8
6.9
11
8
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
13.8
6.9
11
8
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
13.8
6.9
11
8
X19
ICPC
Breast lump/mass female
3.6
6.9
29
82
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
6.9
69
328
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.8
339
2533
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.8
6.8
40
143
6BA02
NOMESCO Finland
NA
11.0
6.8
12
11
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
4.5
6.8
22
49
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.9
6.8
26
68
L01EE03
ATC
binimetinib; oral
40.2
6.8
8
*
1XC08
NOMESCO Finland
NA
40.2
6.8
8
*
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
5.7
6.8
18
32
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
6.7
60
269
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
16.7
6.7
10
6
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.7
6.7
21
45
S50
ICPC
Skin, Medication/prescr/renewal
4.7
6.7
21
45
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.7
6.7
21
45
R52.0
ICD-10 Finland
Acute pain
2.5
6.7
49
200
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.7
6.7
43
160
B01AF01
ATC
rivaroxaban; oral
0.6
6.7
94
1550
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
7.2
6.7
15
21
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
22.6
6.7
9
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
4.9
6.7
20
41
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
12.3
6.6
11
9
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.6
6.6
27
75
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
2.4
6.6
51
215
OAB43
SPAT
NA
0.5
6.6
52
1004
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
8.7
6.5
13
15
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
3.2
6.5
32
102
1CX01
NOMESCO Finland
NA
10.1
6.5
12
12
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
6.9
6.5
15
22
J01FF01
ATC
clindamycin; systemic
1.3
6.5
449
3548
TGD00
NOMESCO Finland
Needle biopsy of lung
5.3
6.5
18
34
8936/1-C17.1
ICD-O-3
Gastrointestinal stromal tumor, NOS, of jejunum
70.1
6.4
7
*
V03AE01
ATC
polystyrene sulfonate; oral
3.2
6.4
31
98
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
4.7
6.4
20
43
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.4
249
1776
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
6.6
6.3
15
23
C83.00
ICD-10 Finland
Lymphocytic lymphoma
8.2
6.3
13
16
SPAT1290
SPAT
Preparation of deceased person
11.1
6.3
11
10
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
11.1
6.3
11
10
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
9.3
6.3
12
13
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.6
6.3
20
44
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.1
6.3
*
213
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.8
6.3
24
63
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.1
6.3
31
100
3026
Kela drug reimbursment
Lorlatinib
+∞
6.3
6
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
6.3
6
*
8936/3-C26.9
ICD-O-3
Gastrointestinal stromal tumor of gastrointestinal tract, NOS
+∞
6.3
6
*
WB502
NOMESCO Finland
Demanding pharmacotherapy for primary neoplasm, enzyme inhibitor or similar agent
+∞
6.3
6
*
3017
Kela drug reimbursment
Brigatinib
+∞
6.3
6
*
ECB20
NOMESCO Finland
Oral alveoplasty
4.3
6.2
21
49
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
26.8
6.2
8
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
26.8
6.2
8
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
26.8
6.2
8
*
D75.2
ICD-10 Finland
Essential thrombocytosis
4.8
6.2
19
40
C10AX09
ATC
ezetimibe; oral
0.6
6.2
86
1424
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
2.4
6.2
49
209
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
7.0
6.2
14
20
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.2
138
862
L04AA06
ATC
mycophenolic acid; systemic
3.0
6.2
33
112
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
2.2
6.2
56
253
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.1
6.2
31
101
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.5
6.2
47
194
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
4.5
6.2
20
45
207
Kela drug reimbursment
Chronic arrhythmias
0.6
6.1
127
1919
L01AA02
ATC
chlorambucil; oral
7.7
6.1
13
17
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
7.7
6.1
13
17
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
12.6
6.1
10
8
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
10.0
6.0
11
11
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
10.0
6.0
11
11
XX4BW
NOMESCO Finland
NA
10.0
6.0
11
11
R31
ICD-10 Finland
Unspecified haematuria
1.5
6.0
179
1205
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
988
3031
5.46
311.21
7.7
3.2
mmol/l
0.8
0.8
0.84
970
2837
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
887
2180
6.51
307.65
12.2
4.3
u/l
285.6
247.1
5.25
869
2057
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1809
9396
10.60
299.51
32.0
6.3
umol/l
10.1
11.7
12.04
1793
8939
(4035726)
658
1678
5.35
250.95
1.6
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1779
10123
7.80
234.66
38.6
9.0
e9/l
3.6
4.1
16.86
1756
8820
(3023368) Bacteria identified in Blood by Culture
1209
5128
4.43
234.44
6.2
4.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
676
2071
4.42
199.69
8.7
4.1
ug/l
27.4
21.0
0.30
607
1703
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1616
9136
4.99
195.97
16.1
7.0
mmol/l
1.2
1.2
0.11
1382
7726
(42870588) Differential panel, method unspecified - Blood
1253
6055
3.86
187.70
13.7
5.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1505
8355
4.23
180.01
12.7
6.1
mmol/l
1.2
1.2
1.32
1470
7561
(3022096) Basophils/100 leukocytes in Blood
1438
7887
3.92
171.53
13.6
6.0
%
0.8
0.7
3.01
1416
7346
(3019069) Monocytes/100 leukocytes in Blood
1461
8129
3.95
169.73
14.3
6.4
%
8.9
8.8
0.61
1439
7589
(3006504) Eosinophils/100 leukocytes in Blood
1454
8102
3.90
167.64
13.8
6.1
%
2.7
2.8
1.19
1432
7529
(3002030) Lymphocytes/100 leukocytes in Blood
1468
8292
3.89
164.31
14.0
6.2
%
26.6
27.3
0.98
1436
7697
(3024561) Albumin [Mass/volume] in Serum or Plasma
1425
7927
3.77
162.61
11.4
4.9
g/l
33.2
35.2
29.79
1389
7378
(3018418) pH of Serum or Plasma
1106
5437
3.31
150.51
10.7
4.1
ph
7.4
7.4
1.39
257
1039
(3006315) Basophils [#/volume] in Blood
1473
8679
3.64
146.55
12.1
5.8
e9/l
0.0
0.0
0.55
1373
7439
(3001604) Monocytes [#/volume] in Blood
1469
8646
3.63
146.29
12.1
5.8
e9/l
0.6
0.6
0.31
1372
7404
(3013115) Eosinophils [#/volume] in Blood
1497
8972
3.65
143.49
13.3
6.1
e9/l
0.2
0.2
0.03
1399
7806
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
217
318
7.53
143.34
2.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
249
426
6.53
142.13
2.7
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1408
8180
3.43
140.87
12.5
5.9
%
57.4
57.6
0.29
1380
7636
(3019198) Lymphocytes [#/volume] in Blood
1477
8842
3.56
140.40
12.3
5.9
e9/l
2.0
1.9
0.05
1388
7720
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
251
444
6.32
138.47
2.7
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1170
6199
3.14
135.24
19.4
3.4
mmol/l
2.3
2.4
1.30
1127
5389
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
742
3033
3.30
134.77
2.7
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
216
357
6.66
127.20
9.6
5.2
iu/ml
314.3
823.5
0.72
43
51
(3004809) Band form neutrophils/100 leukocytes in Blood
195
303
7.02
121.68
7.7
3.7
%
1.7
1.2
1.06
165
241
(3032080) INR in Blood by Coagulation assay
1293
7567
3.00
119.17
8.1
10.1
inr
1.2
1.3
5.32
366
2118
(40758558) Short blood count panel - Blood
896
4457
2.83
109.85
31.9
6.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
212
397
5.85
109.62
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
130
144
9.59
107.67
2.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1841
13696
5.28
106.66
37.1
7.7
u/l
90.1
79.3
12.23
1822
12903
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
271
646
4.70
106.14
3.2
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
185
336
5.96
98.57
6.0
3.6
%
55.5
58.2
1.35
185
336
(3003458) Phosphate [Moles/volume] in Serum or Plasma
595
2511
2.95
97.37
8.9
5.8
mmol/l
1.0
1.0
0.47
570
2325
(3017181) Myelocytes/100 leukocytes in Blood
432
1532
3.32
95.40
9.2
4.1
%
1.3
0.8
2.84
253
466
(3035637) Corticotropin [Mass/volume] in Plasma
142
206
7.34
94.01
1.7
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
988
5484
2.58
93.01
9.1
3.1
u/l
42.2
34.6
1.71
954
5206
(3003434) Protein [Mass/volume] in Pleural fluid
155
252
6.58
92.22
1.4
1.5
g/l
36.5
32.4
3.36
148
227
(3013826) Glucose [Moles/volume] in Serum or Plasma
1527
10518
2.90
91.06
8.1
4.9
mmol/l
6.7
6.8
0.75
1499
9924
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
719
3480
2.66
89.09
10.1
3.1
mmol/l
2.5
2.5
4.58
687
3079
(3044640) Blood type and Crossmatch panel - Blood
999
5705
2.50
86.68
4.3
2.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
158
281
6.02
85.84
4.0
2.6
u/ml
868.3
2140.3
0.46
14
21
(3023199) Leukocytes [#/volume] in Pleural fluid
143
232
6.56
85.16
1.4
1.5
e6/l
1693.2
1788.8
0.12
113
163
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
64
31
21.29
85.00
6.8
3.4
u/l
40.2
39.9
—
26
10
(3028308) Erythrocytes [#/volume] in Pleural fluid
134
207
6.87
83.61
1.4
1.4
e6/l
126318.3
114817.9
0.06
92
118
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
505
2114
2.86
82.20
2.4
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
130
198
6.95
82.19
2.3
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
616
2857
2.67
82.10
3.2
2.1
s
29.8
29.9
0.25
604
2765
(3033658) Prothrombin time (PT) actual/Normal
848
4580
2.48
81.91
7.5
4.0
%
91.3
88.2
3.32
832
4475
(3002179) Metamyelocytes/100 leukocytes in Blood
380
1382
3.16
79.34
9.5
3.9
%
1.0
0.5
3.14
173
337
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
497
2110
2.80
78.36
2.4
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
128
202
6.70
78.21
1.5
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
123
189
6.87
77.07
3.0
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
507
2212
2.73
75.50
5.3
2.6
%
2.0
1.8
1.81
474
1955
(3020779) Urea [Moles/volume] in Serum or Plasma
429
1728
2.89
74.30
9.9
7.6
mmol/l
9.2
10.2
2.11
418
1648
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
125
203
6.50
74.26
3.0
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
382
1453
3.01
73.35
9.5
4.1
%
0.2
0.1
1.29
238
427
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
156
318
5.24
72.94
2.0
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
948
5587
2.32
72.76
4.9
2.6
u/l
59.4
58.0
0.23
919
5158
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1428
17297
0.39
71.60
4.3
5.3
mmol/l
2.7
2.7
0.63
1241
15791
(3004789) Transferrin [Mass/volume] in Serum or Plasma
560
2632
2.57
71.18
2.6
2.6
g/l
2.2
2.3
3.05
537
2447
(3012441) Differential panel - Pleural fluid
121
199
6.41
70.97
1.4
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
78
9
90.20
70.47
12.5
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
136
253
5.69
70.30
2.1
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
553
2615
2.54
69.12
2.2
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
532
2476
2.56
68.71
2.6
2.7
%
21.4
22.7
1.22
483
2111
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
77
78
10.23
67.83
3.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
77
78
10.23
67.83
3.4
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
393
1582
2.85
67.62
5.6
2.2
nmol/l
402.9
370.0
2.82
384
1445
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
85
99
8.92
67.48
3.2
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
85
99
8.92
67.48
3.2
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
85
99
8.92
67.48
3.2
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
85
99
8.92
67.48
3.2
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
134
256
5.54
67.27
2.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
77
79
10.10
67.22
3.4
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
917
5463
2.25
66.99
3.9
3.3
e6/l
52.9
81.3
0.95
781
4230
(3042631) Mycobacterium sp identified in Specimen
134
257
5.52
66.98
2.3
2.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
577
2835
2.45
65.97
2.7
2.6
umol/l
11.8
12.8
2.85
557
2628
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
106
164
6.77
65.90
2.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
106
164
6.77
65.90
2.9
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
106
164
6.77
65.90
2.9
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
123
223
5.81
65.29
1.6
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1375
16800
0.42
64.73
4.1
4.7
mmol/l
1.4
1.5
12.45
1203
15322
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
344
1321
2.94
64.35
1.9
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
403
1686
2.74
64.13
6.0
2.6
e9/l
72.0
70.2
0.43
311
1290
(3042111) Morphology [Interpretation] in Bone marrow Narrative
155
350
4.72
64.12
2.2
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
419
1799
2.68
63.28
2.7
2.2
g/l
0.2
0.2
2.24
392
1691
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
249
800
3.41
63.00
2.2
1.9
ug/l
7.0
2.3
0.42
235
718
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1400
16935
0.42
62.03
4.1
4.7
mmol/l
4.5
4.6
1.71
1229
15556
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
442
1982
2.58
60.88
5.6
2.7
umol/l
10.5
8.8
0.71
422
1759
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
132
285
4.89
57.56
1.3
1.4
u/ml
108.9
128.1
0.56
23
52
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
125
258
5.10
57.46
1.1
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
835
5030
2.13
56.74
3.9
3.2
e6/l
0.6
0.5
0.51
706
3820
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
140
322
4.60
56.52
1.3
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
337
1366
2.76
56.50
9.3
4.2
%
0.3
0.3
0.05
193
363
(3009214) Lutropin [Units/volume] in Serum or Plasma
134
298
4.75
56.38
1.5
1.3
u/l
15.1
10.4
2.02
112
238
(3020630) Protein [Mass/volume] in Serum or Plasma
377
1637
2.61
55.01
3.9
2.9
g/l
64.2
66.5
5.92
361
1503
(21494434) Karyotype in Bone marrow
107
201
5.57
54.61
1.5
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
175
488
3.83
54.61
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1197
8330
2.09
54.36
6.9
4.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
139
330
4.45
53.90
1.3
1.3
—
18.2
—
0
9
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1314
16106
0.46
53.57
5.7
6.2
mmol/mol
40.3
40.4
0.12
1176
14797
(3037692) Legionella sp identified in Specimen by Organism specific culture
63
68
9.53
52.93
1.7
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1497
11441
2.22
51.80
5.2
4.6
e6/l
1088.6
1716.7
0.29
24
168
(3026782) Osmolality of Urine
637
3564
2.15
51.38
3.4
2.8
mosm/kgh2o
536.0
549.9
0.91
588
3041
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
746
4441
2.08
51.01
4.1
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1111
7647
2.02
50.49
24.3
10.0
e9/l
0.0
0.0
2.82
996
6240
(3045788) Cell count panel - Pleural fluid
99
187
5.52
50.20
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1345
16253
0.47
49.34
3.9
4.2
mmol/l
1.5
1.3
5.15
1170
14703
(3017354) Segmented neutrophils/100 leukocytes in Blood
98
187
5.46
49.14
9.8
3.6
%
55.0
56.4
0.18
66
126
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
222
775
3.10
48.54
3.3
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
121
281
4.52
48.19
1.8
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
112
249
4.71
47.07
1.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
784
4859
2.01
47.07
3.9
3.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
196
649
3.24
46.81
4.3
3.1
g/l
0.3
0.3
0.40
158
263
(44790047)
101
209
5.04
46.22
2.6
1.5
—
—
—
0
0
(44806118)
101
209
5.04
46.22
2.6
1.5
—
—
—
0
0
(44790049)
101
209
5.04
46.22
2.6
1.5
—
—
—
0
0
(44790048)
101
209
5.04
46.22
2.6
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
169
522
3.44
45.10
3.5
2.1
%
91.9
90.0
0.52
164
494
(3018095) Leukocytes [#/volume] in Urine
944
6302
1.94
45.08
4.5
3.8
e6/l
86.2
124.5
0.65
793
4547
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
203
710
3.07
44.12
3.5
3.5
u/ml
64.1
2151.8
0.86
177
608
(3021879) Hepatitis B virus core Ab [Presence] in Serum
252
1002
2.73
43.25
1.4
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
71
112
6.54
43.25
4.0
2.1
e6/l
1827.8
719.6
0.38
35
48
(3024471) HLA-A [Type]
48
47
10.44
43.20
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
100
218
4.78
43.02
13.6
4.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
30
12
25.37
42.58
1.3
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
200
712
3.01
42.09
2.3
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1028
7178
1.89
41.68
2.7
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
615
3636
2.00
41.06
10.3
4.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
154
477
3.41
40.85
2.3
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
67
107
6.44
40.32
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
299
1335
2.46
40.28
4.0
2.8
g/l
9.1
10.7
8.16
280
1219
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
161
519
3.29
40.05
1.8
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
75
135
5.73
40.01
2.7
1.9
%
25.6
47.6
3.97
14
17
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
107
261
4.27
39.97
6.1
2.2
u/ml
301.4
66.8
1.06
107
251
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
261
1103
2.57
39.48
1.6
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
45
46
9.98
39.27
1.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
630
3819
1.95
38.70
3.1
2.6
e6/l
6.0
5.3
0.32
579
3358
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
185
661
2.98
38.61
3.9
3.0
u/ml
0.4
0.3
0.65
115
386
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
224
896
2.69
37.81
2.0
1.8
g/l
1.6
1.5
0.36
197
775
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
266
1157
2.50
37.80
4.1
3.7
mmol/l
1.6
1.9
0.69
196
870
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
348
1706
2.26
37.68
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
328
1576
2.29
37.23
1.5
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
131
388
3.54
37.20
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
131
388
3.54
37.20
1.6
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
272
1205
2.45
37.12
4.1
3.7
ph
7.4
7.4
0.05
28
156
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
161
544
3.13
37.00
1.6
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
79
161
5.07
36.77
4.2
1.9
e9/l
1.1
1.0
0.03
37
97
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
318
1516
2.30
36.73
9.3
3.8
mmol/l
1.2
1.2
0.37
308
1325
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
513
2943
2.00
36.67
3.5
3.0
e6/l
2.4
2.2
0.20
335
1625
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
272
1221
2.42
36.00
4.1
3.7
kpa
5.1
5.2
0.88
248
1135
(40768441) Liver Pathology biopsy report
68
128
5.46
34.58
1.4
1.3
—
—
—
0
0
(3036489) Thrombin time
176
652
2.86
34.32
3.4
2.0
s
21.8
21.7
0.16
169
585
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
70
141
5.11
33.02
1.5
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
70
141
5.11
33.02
1.8
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
73
153
4.91
32.89
2.4
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
38
40
9.66
32.44
3.5
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
70
147
4.90
31.47
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
56
96
5.97
31.41
4.2
3.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
398
2205
2.00
30.79
6.5
7.2
mmol/l
1.3
1.1
0.60
305
1723
(3023419) Bacteria identified in Sputum by Culture
95
259
3.80
30.46
2.6
2.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
46
67
7.00
30.17
2.5
1.8
u/ml
44373.5
4114.2
—
10
9
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
65
133
5.02
30.12
1.4
1.4
u/l
11.2
13.6
1.99
65
126
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
47
71
6.75
29.81
1.3
1.5
%
71.5
59.1
1.24
34
56
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
57
106
5.51
29.37
5.1
2.0
e6/l
1224.3
537.1
0.55
49
90
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
249
1173
2.28
29.24
1.8
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
122
402
3.17
29.18
6.5
4.9
mmol/l
2.8
2.5
0.55
96
278
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
392
2203
1.97
28.94
6.6
7.3
kpa
5.0
5.1
2.51
373
2107
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
104
313
3.45
28.78
1.2
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
391
2204
1.96
28.58
6.6
7.3
kpa
12.1
12.2
0.13
370
2106
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
30
27
11.26
28.48
2.2
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
22
11
20.21
28.44
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
317
1665
2.07
28.22
3.0
2.4
u/l
72.8
40.0
0.39
290
1432
(3028433) Virus identified in Specimen by Culture
43
63
6.95
28.05
1.6
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
118
394
3.12
27.60
4.8
4.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
67
152
4.53
27.45
1.5
1.4
u/l
35.3
33.3
0.16
61
120
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
27
22
12.43
27.26
1.1
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
227
1060
2.29
27.14
3.3
1.8
g/l
1.9
1.5
0.77
200
972
(3001964) Herpes simplex virus Ag [Presence] in Specimen
39
54
7.35
26.75
2.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1489
16806
0.56
26.74
5.0
4.9
mmol/l
6.1
6.0
1.09
1308
15198
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
36
46
7.95
26.43
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
312
1671
2.03
26.21
6.6
7.0
mmol/l
1.5
1.4
1.60
296
1610
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
96
292
3.40
26.14
1.2
1.2
u/ml
312.9
265.0
0.75
65
170
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
53
103
5.26
26.04
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
53
103
5.26
26.04
1.8
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
58
124
4.79
25.54
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
36
48
7.62
25.50
5.6
2.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
42
67
6.38
25.30
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
499
3145
1.78
25.29
3.3
2.8
e6/l
1.2
1.1
0.12
324
1821
(3010421) pH of Blood
129
477
2.82
25.15
6.3
4.5
ph
7.4
7.4
0.32
121
397
(3001893) Eosinophils/100 leukocytes in Pleural fluid
40
61
6.67
25.15
1.2
1.6
%
2.9
3.3
0.07
29
51
(3026008) Bacteria identified in Urine by Culture
765
5431
1.66
25.02
3.2
3.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
783
5618
1.65
24.40
3.2
3.1
ng/l
1567.2
1331.6
0.76
717
4842
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
658
4524
1.68
24.16
2.2
2.2
mg/l
3.6
3.0
4.10
586
3840
(3002032) Base excess in Venous blood by calculation
314
1732
1.96
24.13
5.5
3.7
mmol/l
1.9
2.0
0.13
240
1401
(40767503) Oxygen content in Capillary blood by calculation
113
398
2.95
24.08
2.8
2.6
%
15.6
16.1
0.44
47
208
(3048929) Epstein Barr virus Ab [Presence] in Serum
116
415
2.91
24.03
1.2
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
115
410
2.91
23.97
2.3
2.7
umol/l
39.4
34.1
1.22
92
349
(3019225) pH of Specimen
335
1911
1.90
23.23
11.1
4.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
51
106
4.91
23.23
2.4
2.7
%
35.5
38.5
0.30
13
37
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
169
746
2.38
22.91
4.7
4.0
mmol/l
24.7
24.9
0.29
156
701
(3019060) Gas panel - Arterial blood
248
1283
2.06
22.74
4.0
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
190
887
2.26
22.62
4.4
3.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
43
79
5.54
22.46
1.6
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
55
126
4.46
22.28
2.7
1.8
%
64.9
73.0
1.63
48
116
(3026493) Urate [Moles/volume] in Serum or Plasma
675
4751
1.63
22.20
7.1
2.8
umol/l
2916.0
5820.7
1.09
610
4092
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
538
3575
1.69
22.12
4.5
3.9
ng/l
424.6
391.6
0.09
445
2929
(3014576) Chloride [Moles/volume] in Serum or Plasma
399
2438
1.80
22.11
9.0
6.9
mmol/l
103.6
104.2
1.72
394
2377
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
208
1019
2.16
21.97
8.0
9.5
mmol/l
24.3
24.3
0.00
196
957
(3021447) Carbon dioxide [Partial pressure] in Venous blood
308
1739
1.91
21.95
5.6
3.7
kpa
5.7
5.8
0.83
303
1693
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1853
16891
2.30
21.86
46.4
15.6
mg/l
27.3
25.1
2.11
1799
13517
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
285
4787
0.53
21.84
1.6
1.7
mmol/l
1.8
1.4
3.00
231
3975
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
124
4.45
21.82
1.8
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
132
535
2.57
21.49
3.8
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1414
11918
1.63
21.37
5.6
4.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
24
24
10.11
21.18
1.5
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
913
6974
1.57
20.92
4.2
3.8
ng/l
28.9
60.8
2.06
781
5095
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
113
436
2.69
20.31
3.3
3.3
u/ml
291.0
932.6
0.52
105
405
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
763
5621
1.58
20.30
3.4
2.2
u/l
169.7
221.7
1.24
730
5273
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
17
10
17.14
20.30
1.1
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
52
123
4.31
20.25
2.8
1.8
%
12.3
13.6
0.20
14
48
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
65
182
3.66
20.09
2.8
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
67
194
3.54
19.71
3.4
3.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
115
457
2.61
19.49
1.6
1.3
iu/l
26.0
33.6
1.64
94
392
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
194
975
2.10
19.12
4.0
3.3
pmol/l
4.2
4.4
1.40
176
854
(3007853) Bacteria identified in Skin by Aerobe culture
337
2039
1.78
19.06
1.8
1.8
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
20
18
11.21
18.89
1.2
1.6
%
22.2
16.7
0.20
15
11
(1761868) Lipid panel - Serum or Plasma
362
5505
0.58
18.88
2.7
3.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
31
49
6.41
18.84
1.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
59
162
3.72
18.78
1.1
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
44
98
4.57
18.48
7.5
6.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
177
876
2.12
18.15
6.7
4.1
mmol/l
24.0
24.2
0.25
169
783
(21494814) CD8 cells/100 lymphocytes in Specimen
36
69
5.29
17.99
1.7
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
326
1985
1.77
17.97
7.2
7.6
%
95.0
95.6
0.72
310
1913
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
30
49
6.20
17.67
1.2
1.2
ug/l
747.5
67.8
1.34
22
22
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
89
328
2.79
17.48
1.3
1.2
u/l
110.1
45.2
1.12
76
290
(3000919) Neutrophils/100 leukocytes in Pleural fluid
33
60
5.58
17.45
1.3
1.5
%
8.9
28.0
3.94
25
54
(40768793) Breast Pathology biopsy report
103
410
2.59
17.41
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
271
1593
1.81
16.76
9.5
8.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
27
42
6.50
16.66
3.3
5.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
44
107
4.18
16.56
2.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
43
103
4.24
16.51
2.8
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
43
103
4.24
16.51
2.8
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
105
439
2.47
16.03
3.6
3.1
kpa
8.1
8.0
0.37
96
401
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
119
3.93
15.95
2.9
1.8
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
21
26
8.15
15.77
1.2
1.9
%
2.6
5.8
0.86
11
14
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
527
3753
1.55
15.40
2.2
1.8
mg/l
2.3
1.3
3.23
456
2907
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
37
84
4.47
15.21
1.5
2.0
%
99.8
99.5
0.02
37
79
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
42
106
4.03
15.07
2.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
168
877
2.00
14.88
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
68
238
2.92
14.72
2.1
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
42
108
3.95
14.70
4.3
3.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
68
239
2.91
14.61
2.1
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
50
146
3.49
14.58
7.3
4.8
u/ml
318.5
43.2
0.74
21
41
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
68
241
2.89
14.39
2.1
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
96
405
2.44
14.39
2.5
2.3
g/l
123.6
129.7
1.15
58
302
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
40
101
4.02
14.35
1.6
1.6
u/l
3.0
7.7
1.41
24
56
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
269
1654
1.72
14.13
3.0
3.0
ng/l
167.6
197.3
0.88
246
1516
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
67
238
2.88
14.13
2.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
67
238
2.88
14.13
2.1
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
36
85
4.29
14.10
2.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
36
85
4.29
14.10
2.3
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
303
1930
1.67
13.96
4.7
3.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
67
240
2.85
13.92
2.1
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
36
87
4.20
13.69
3.6
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
319
2080
1.63
13.38
2.4
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
108
498
2.24
13.23
3.1
3.3
mmol/l
24.3
25.3
1.22
90
432
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
91
391
2.39
13.12
2.0
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
25
46
5.49
13.07
1.2
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
46
5.49
13.07
1.1
1.4
%
79.6
88.0
0.44
19
25
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
46
5.49
13.07
1.1
1.1
%
78.9
88.5
0.74
19
24
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
71
273
2.66
12.92
1.2
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
86
363
2.43
12.90
1.2
1.2
titre
108.0
348.9
—
5
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
25
47
5.37
12.78
1.1
1.1
%
90.3
106.7
0.97
25
42
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
100
459
2.24
12.40
1.5
2.0
mg/l
10.6
11.9
0.62
89
425
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
28
60
4.72
12.36
1.5
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
35
6.05
12.13
1.6
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
100
464
2.22
12.08
7.9
3.2
mg/l
1.5
1.6
0.90
94
419
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
51
171
3.03
11.95
1.2
1.2
u/l
59.7
52.3
0.51
37
127
(46235355) HIV 1 and 2 tests - Meaningful Use set
300
1984
1.60
11.79
1.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
84
366
2.35
11.77
3.2
2.9
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
28
64
4.42
11.45
2.0
2.0
e6/l
12068.0
27383.8
0.25
13
42
(3002256) Pathology report gross observation
345
2372
1.55
11.44
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
1110
0.33
11.42
1.3
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
160
3.05
11.37
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
60
228
2.68
11.21
1.1
1.2
u/ml
1.3
4.2
1.17
18
70
(3044007) Cell count panel - Peritoneal fluid
25
53
4.76
11.19
2.3
1.9
—
—
—
0
0
(4268621)
46
151
3.09
11.19
2.1
2.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
279
1835
1.60
11.19
8.1
8.0
g/l
119.3
121.1
0.66
269
1769
(3024354) Oxygen [Partial pressure] in Venous blood
228
1426
1.68
11.16
5.2
3.1
kpa
4.6
4.6
0.06
223
1385
(3023487) Leukocytes [#/volume] in Peritoneal fluid
30
74
4.10
11.14
2.1
2.2
e6/l
1103.6
766.2
0.30
20
63
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
86
388
2.27
11.13
1.3
1.9
iu/l
2.5
4.6
2.79
21
133
(3037522) Nuclear Ab [Titer] in Serum
325
2230
1.55
10.83
1.3
1.3
titre
502.2
527.0
0.08
74
506
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
65
262
2.53
10.80
8.3
6.7
mg/l
11.0
12.0
1.23
60
246
(3048879) Bone marrow aspiration report
27
63
4.33
10.77
3.2
1.8
—
—
—
0
0
(4306422)
57
217
2.67
10.62
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
227
1437
1.65
10.60
4.4
4.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
15
20
7.55
10.56
7.5
2.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
22
44
5.04
10.52
1.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
227
3435
0.62
10.49
1.2
1.2
u/ml
1.0
1.5
1.09
50
890
(3020393) Adenovirus Ag [Presence] in Stool
12
12
10.05
10.44
1.9
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
197
1206
1.70
10.44
5.5
6.7
mmol/l
24.9
24.6
0.65
183
1125
(21494755) Public health laboratory ask at order entry panel
34
1002
0.33
10.41
1.0
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
79
355
2.28
10.34
1.3
1.4
mmol/l
58.8
59.7
0.06
64
284
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
35
103
3.44
10.16
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
15
21
7.19
10.14
1.7
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
15
21
7.19
10.14
1.7
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
15
21
7.19
10.14
1.7
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
42
139
3.06
10.10
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
725
0.23
10.06
1.1
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
572
4441
1.40
10.01
1.5
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
391
5240
0.68
10.01
3.3
4.6
%
20.9
21.3
0.24
186
2712
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
57
224
2.59
9.99
1.1
1.2
u/ml
2.7
6.2
1.50
32
96
(3014891) Appearance of Pleural fluid
17
28
6.11
9.93
1.9
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
842
6981
1.36
9.76
3.2
2.8
ug/l
328.1
143.3
12.60
793
6387
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
41
137
3.03
9.71
1.5
1.4
nmol/l
0.2
0.3
0.70
29
101
(3013512) EKG study
688
5539
1.37
9.58
5.4
4.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
46
166
2.81
9.52
1.1
1.2
%
103.2
94.9
1.23
46
158
(3047181) Lactate [Moles/volume] in Blood
110
580
1.95
9.51
5.3
6.2
mmol/l
1.3
1.3
0.02
94
509
(3000093) Morphology [Interpretation] in Blood Narrative
49
183
2.72
9.51
1.1
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
17
30
5.71
9.28
1.4
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
27
5.97
9.12
1.7
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
69
311
2.26
9.01
1.1
1.2
miu/ml
241.1
220.2
0.12
16
127
(40757373) Influenza virus identified in Isolate
20
43
4.69
8.82
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
267
3770
0.66
8.78
2.6
3.2
ug/l
0.9
0.8
0.98
192
2640
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
81
394
2.10
8.76
1.5
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
54
222
2.47
8.67
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
43
158
2.76
8.63
1.1
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
13
19
6.88
8.44
1.6
2.3
mg/l
1.0
1.1
—
7
14
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
37
129
2.90
8.18
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
88
457
1.97
7.99
1.1
1.2
titre
168.0
90.3
—
5
32
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
1037
1.64
7.92
11.0
10.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
105
3.08
7.87
1.1
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
46
184
2.54
7.85
1.8
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
23
62
3.74
7.63
1.8
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
483
6030
0.74
7.61
3.9
4.1
mg/mmol
19.6
8.4
3.24
322
3803
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
35
124
2.86
7.54
1.7
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
44
176
2.53
7.52
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
55
244
2.29
7.50
1.1
1.1
g/l
1.6
1.5
0.73
50
222
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
29
5.20
7.45
1.7
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
11
7
15.80
7.23
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
11
7
15.80
7.23
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
11
7
15.80
7.23
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
11
7
15.80
7.23
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
11
7
15.80
7.23
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
294
2.14
7.21
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
459
5737
0.74
7.20
3.3
3.3
mg/l
1244.9
304.6
1.87
321
3632
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
34
4.74
7.16
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
398
1.97
7.12
1.4
1.2
—
—
—
0
0
(4015189)
21
57
3.71
6.91
2.2
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
476
5891
0.75
6.91
3.1
3.2
mmol/l
7.0
7.4
1.08
381
4933
(3019550) Sodium [Moles/volume] in Serum or Plasma
1857
17796
1.60
6.90
44.1
18.2
mmol/l
138.8
139.7
35.02
1837
17361
(3051611) Lipemic interference index of Serum or Plasma
45
190
2.40
6.88
4.3
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
56
260
2.19
6.88
1.2
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
13
24
5.45
6.77
1.2
1.1
%
64.7
75.2
—
7
5
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
94
3.01
6.66
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
94
3.01
6.66
1.1
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
122
743
1.68
6.64
1.5
1.9
u/l
43.4
38.6
1.79
105
652
(3019309) Folate [Moles/volume] in Red Blood Cells
444
3511
1.34
6.53
1.8
1.8
nmol/l
1181.1
1184.8
0.02
358
2639
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
37
4.35
6.49
1.3
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
30
107
2.83
6.43
2.7
3.0
ph
7.4
7.4
0.37
12
40
(3023103) Potassium [Moles/volume] in Serum or Plasma
1857
17841
1.56
6.28
45.0
18.4
mmol/l
4.0
4.0
4.68
1834
17386
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
39
4.13
6.09
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
28
100
2.83
6.00
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
629
0.37
5.84
2.1
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
112
1745
0.62
5.69
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
170
1169
1.50
5.56
3.5
3.2
e9/l
5.5
4.1
1.08
140
876
(3016038) Potassium [Moles/volume] in Urine
32
128
2.52
5.54
1.2
1.2
mmol/l
36.1
33.9
0.20
32
113
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
12
25
4.82
5.49
1.2
1.1
%
51.4
80.5
—
5
6
(3022217) INR in Platelet poor plasma by Coagulation assay
325
2514
1.35
5.47
13.7
26.0
inr
1.3
1.4
0.96
64
359
(3026250) Tacrolimus [Mass/volume] in Blood
20
62
3.25
5.45
44.4
31.3
ug/l
8.7
7.0
3.09
15
55
(3020891) Body temperature
121
775
1.60
5.44
4.7
4.5
—
—
—
0
0
(3000012) Reticulocyte production index
27
103
2.64
5.15
2.9
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
33
140
2.38
5.07
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
723
0.46
5.00
1.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
22
77
2.88
4.93
1.0
1.1
ratio
1.0
1.1
—
9
26
(3000060) B lymphocytes [#/volume] in Blood
14
37
3.80
4.81
5.3
2.0
e6/l
120.0
222.7
—
6
15
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
72
416
1.76
4.81
1.2
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
7
11.47
4.78
2.3
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
132
896
1.51
4.63
3.9
2.7
%
1.2
1.2
0.02
132
890
(3021960) Folate [Moles/volume] in Serum or Plasma
522
4392
1.26
4.59
1.7
1.6
nmol/l
17.6
20.5
5.25
481
3709
(36660697) Celiac disease serology panel - Serum
76
1229
0.60
4.54
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
476
0.37
4.54
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
561
6525
0.81
4.48
3.8
5.3
ug/l
2.5
3.0
0.90
491
5817
(3033705) Calcium.ionized [Moles/volume] in Venous blood
44
222
2.00
4.47
2.9
2.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
81
495
1.66
4.44
1.8
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
1129
0.60
4.33
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
45
3.35
4.32
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1465
13767
1.24
4.29
57.1
19.0
%
15.1
13.8
122.59
1452
13459
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
115
773
1.52
4.24
5.1
5.2
%
1.7
1.6
0.46
107
722
(3014007) Fractional oxyhemoglobin in Arterial blood
170
1234
1.41
4.23
10.0
9.0
%
92.6
94.0
1.18
170
1227
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
41
3.43
4.18
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
515
4368
1.24
4.17
4.1
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
728
0.53
3.95
1.3
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
69
419
1.67
3.92
6.3
6.9
mmol/l
11.0
11.2
0.22
62
373
(3018572) Chloride [Moles/volume] in Blood
69
419
1.67
3.92
6.3
6.9
mmol/l
104.4
105.2
0.93
62
373
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
14
43
3.27
3.91
6.0
2.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
85
546
1.58
3.86
1.3
1.5
ug/g
239.6
277.5
0.92
55
328
(40768446) Kidney Pathology biopsy report
18
65
2.79
3.85
1.1
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
5
12.03
3.76
2.7
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
193
1462
1.35
3.73
3.6
3.9
ng/l
103.9
91.9
0.88
171
1267
(3019832) Treponema pallidum Ab [Presence] in Serum
100
672
1.51
3.73
1.3
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
60
357
1.70
3.69
1.2
1.2
u/ml
1.2
5.0
—
7
26
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
210
1.92
3.69
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
28
565
0.49
3.63
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
85
2.49
3.63
1.7
2.6
u/ml
1636.6
1449.1
0.15
21
85
(4010399)
175
1313
1.36
3.60
1.7
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
52
300
1.75
3.57
1.1
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
68
2.66
3.56
3.4
2.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
183
1387
1.35
3.54
2.5
2.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
6
10.02
3.50
2.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
39
695
0.55
3.42
1.1
1.1
titre
—
153.6
—
0
14
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
42
3.11
3.37
1.0
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
165
1243
1.36
3.33
9.8
8.8
%
1.3
1.3
0.16
165
1233
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
14
48
2.93
3.30
1.2
1.5
ug/l
12.2
3.0
—
8
36
(3000492) Spirometry study
194
1500
1.32
3.29
2.3
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
96
658
1.48
3.29
1.9
3.8
mg/l
54.9
60.3
0.18
77
539
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
29
142
2.06
3.27
1.2
1.1
—
4.3
—
0
9
(4062490)
30
149
2.03
3.26
1.3
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
13
43
3.04
3.25
2.5
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
15
5.35
3.19
1.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
15
5.35
3.19
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
291
0.34
3.18
1.8
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
91
2.32
3.17
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
345
0.40
3.10
1.8
1.8
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
8
7.52
3.05
1.3
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
117
846
1.41
3.04
4.4
3.9
%
50.8
48.6
0.47
117
835
(3014765) Yersinia sp identified in Stool by Organism specific culture
75
497
1.53
3.04
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
818
0.61
3.03
1.3
1.8
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
21
4.30
2.99
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
74
491
1.53
2.99
1.1
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
94
657
1.45
2.95
1.9
3.8
mg/l
33.6
82.2
1.50
75
539
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
31
162
1.93
2.95
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
211
1679
1.29
2.92
2.2
2.5
ug/l
8.9
7.2
0.45
186
1497
(42529406) Shigella sp [Presence] in Stool by Culture
75
502
1.51
2.92
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
522
4576
1.19
2.90
4.6
4.2
estimate
0.0
0.0
0.11
204
1509
(4281824)
34
186
1.84
2.83
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1140
10651
1.16
2.83
5.3
3.2
u/l
95.8
52.8
9.88
1081
9830
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
91
638
1.45
2.82
1.9
3.8
ratio
1.5
1.6
—
6
49
(3007930) Methemoglobin/Hemoglobin.total in Blood
106
765
1.41
2.81
5.4
5.2
%
0.8
0.9
0.38
97
717
(3016750) Collection duration of Urine
24
117
2.06
2.77
1.7
2.1
min
475.7
484.7
0.17
17
84
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1849
18050
1.32
2.77
41.2
11.1
u/l
26.7
25.7
1.77
1832
17383
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
29
152
1.92
2.75
1.2
1.1
—
61.0
—
0
14
(3040151) Glucose [Moles/volume] in Capillary blood
37
210
1.78
2.75
5.2
6.7
mmol/l
7.0
7.4
0.47
31
177
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
67
445
1.52
2.72
1.2
1.2
u/ml
2.3
3.8
—
7
44
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
48
2.72
2.72
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1360
12915
1.17
2.61
7.5
4.0
pmol/l
15.2
14.9
3.69
1287
11628
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
277
0.39
2.61
1.7
1.8
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
148
1.90
2.61
1.4
1.4
g/l
0.4
0.4
0.30
20
101
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
148
1.90
2.61
1.4
1.4
g/l
2.6
2.8
0.32
19
103
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
148
1.90
2.61
1.4
1.4
g/l
7.9
6.8
0.49
20
102
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
15
4.68
2.59
1.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
100
2.11
2.59
3.9
1.8
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
29
156
1.87
2.57
1.2
1.1
—
64.3
—
0
7
(3046861) Legionella sp Ag [Presence] in Urine
5
7
7.16
2.55
1.0
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
915
8454
1.15
2.53
4.2
3.8
estimate
0.0
0.0
1.08
227
1515
(3043410) Blood group antigens tested for on Red Blood Cells
14
56
2.51
2.53
3.1
2.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
67
453
1.50
2.52
1.2
1.2
u/ml
4.5
8.8
0.64
12
74
(3044941) Cell count panel - Synovial fluid
14
314
0.44
2.52
1.1
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
179
1.80
2.52
2.3
1.9
u/l
67.2
818.9
—
9
62
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
40
646
0.61
2.50
1.0
1.1
—
2.0
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
59
391
1.52
2.45
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
185
1485
1.27
2.42
7.6
2.8
ml/min/173m2
52.8
63.2
4.25
87
618
(3004616) Nuclear Ab [Presence] in Serum
38
227
1.69
2.40
1.4
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
191
0.36
2.40
1.0
1.0
—
2.2
—
0
67
(4094501)
30
514
0.58
2.38
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
475
0.56
2.36
1.4
1.7
e6/l
11960.7
15428.5
0.38
22
341
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
58
387
1.51
2.35
1.3
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
52
339
1.55
2.33
1.4
1.5
pmol/l
117.5
233.0
1.44
52
334
(3037756) Immunofixation for Serum or Plasma
65
445
1.48
2.33
1.5
1.7
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
9
28
3.22
2.30
1.4
1.2
u/l
3246.0
1232.1
—
9
20
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
215
1.69
2.29
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1788
17440
1.24
2.27
35.0
14.8
—
—
—
0
0
(44806071)
7
18
3.90
2.25
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
900
8354
1.14
2.24
5.6
5.1
estimate
0.0
0.0
0.50
232
1583
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
287
1.58
2.23
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
36
217
1.67
2.22
1.3
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
231
2757
0.82
2.22
1.2
1.3
u/ml
11.4
13.4
0.15
68
1031
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
80
2.13
2.18
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
28
158
1.78
2.18
1.9
2.3
ml
637.6
618.1
0.10
18
101
(3035350) Ketones [Presence] in Urine by Test strip
896
8330
1.14
2.16
4.2
3.8
estimate
0.0
0.0
0.00
230
1558
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
19
3.69
2.15
4.1
5.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
57
387
1.49
2.15
3.8
3.4
mmol/l
7.6
7.6
0.02
57
377
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1673
16237
1.18
2.11
45.6
14.6
ml/min/173m2
75.4
77.3
3.16
1582
13494
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
25
3.21
2.09
1.4
2.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
10
5.01
2.07
7.4
4.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
18
89
2.03
2.06
2.1
2.8
ml
1808.9
1877.6
0.10
18
77
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
44
2.51
2.01
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
97
1.97
2.00
3.3
2.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1317
13733
0.88
1.97
59.7
20.6
g/l
329.1
332.0
20.37
1306
13639
(4212803)
7
21
3.34
1.96
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
45
2.45
1.93
2.1
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
147
1184
1.26
1.92
2.2
2.2
nmol/l
11.2
12.7
1.47
133
1026
(3014271) Vancomycin [Susceptibility]
19
99
1.93
1.90
3.4
2.8
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
51
0.00
1.88
0.0
2.2
—
139.7
—
0
44
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
73
534
1.38
1.88
1.4
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
66
475
1.40
1.87
4.9
4.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
197
2346
0.82
1.87
13.3
7.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
34
2.65
1.86
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
19
100
1.91
1.85
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
122
1.81
1.84
1.7
1.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
10
40
2.51
1.83
1.2
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
126
1004
1.27
1.81
1.2
1.2
iu/ml
162.6
137.3
0.20
30
373
(3044889) 12 lead EKG panel
1306
12506
1.13
1.81
5.6
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
253
2172
1.19
1.78
1.4
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
137
0.36
1.75
4.0
3.9
%
14.0
13.3
—
5
137
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
36
2.51
1.74
1.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
48
0.00
1.69
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
34
219
1.56
1.68
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
150
1814
0.81
1.68
2.2
2.3
ug/g
249.8
150.9
1.14
122
1428
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
334
1.45
1.66
3.3
3.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
31
2.59
1.66
2.0
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
49
2.25
1.63
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
410
0.63
1.57
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
50
2.21
1.57
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
685
6364
1.12
1.55
4.5
4.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
107
1.78
1.54
2.2
1.6
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
42
0.00
1.52
0.0
2.2
—
3.3
—
0
17
(3024980) IgG subclass 4 [Mass/volume] in Serum
37
251
1.48
1.48
1.4
1.6
g/l
1.0
0.9
0.11
25
190
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
726
1.28
1.47
3.1
2.7
g/l
3.6
3.1
2.92
67
583
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
95
1.80
1.43
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
39
2.31
1.43
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
776
1.26
1.40
3.0
2.6
g/l
8.0
7.4
1.45
68
595
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
776
1.26
1.40
3.0
2.6
g/l
3.8
3.8
0.07
67
573
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
776
1.26
1.40
3.0
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
189
2195
0.85
1.40
1.3
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
41
2.20
1.37
1.6
2.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
17
2.95
1.36
1.2
1.1
nmol/l
0.0
0.1
—
5
7
(40768800) Prostate Pathology biopsy report
30
442
0.67
1.35
1.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
47
2.13
1.33
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
91
728
1.26
1.33
3.1
2.7
g/l
10.2
10.4
0.14
72
628
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
40
0.00
1.32
0.0
1.6
—
1.7
—
0
19
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
27
176
1.54
1.31
1.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
49
360
1.37
1.31
3.5
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
24
2.50
1.30
2.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
43
2.10
1.30
1.1
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
97
786
1.25
1.28
1.3
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
44
2.05
1.27
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
44
2.05
1.27
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
44
2.05
1.27
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
44
2.05
1.27
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
97
794
1.23
1.19
2.5
2.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
32
224
1.44
1.14
1.7
1.3
mu/l
34.0
58.0
0.98
27
197
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
65
1.85
1.13
1.9
2.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
193
1.46
1.09
1.1
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
32
2.19
1.08
1.3
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
72
578
1.25
1.07
3.0
2.6
g/l
0.4
0.0
0.46
67
539
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
116
982
1.19
1.04
2.5
2.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
112
946
1.19
1.03
1.3
1.3
u/ml
163.4
226.0
0.71
90
868
(3001686) Cold agglutinin [Titer] in Serum or Plasma
9
47
1.92
1.02
1.1
1.4
titre
—
127.3
—
0
9
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
584
0.77
1.00
1.7
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
64
512
1.26
0.99
1.5
1.6
iu/ml
35.5
12.4
0.28
21
98
(3004716) Salmonella sp identified in Stool by Organism specific culture
87
723
1.21
0.96
1.3
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
85
1.65
0.94
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
150
1.47
0.93
1.8
2.1
u/field
1.9
2.1
—
9
60
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
52
1.73
0.92
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
67
550
1.23
0.86
3.1
2.6
g/l
0.0
0.0
0.49
62
512
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
212
2347
0.89
0.85
3.5
4.7
%
29.6
32.8
4.36
153
1532
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
27
366
0.73
0.84
2.1
1.7
nmol/l
44.3
41.7
0.20
27
346
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
57
1.76
0.83
2.0
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
57
1.76
0.83
2.0
2.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
97
1.55
0.81
1.5
1.8
—
—
—
0
0
(4034850)
46
576
0.79
0.81
13.9
10.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
271
0.70
0.80
1.1
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
66
546
1.22
0.80
3.1
2.6
g/l
0.0
0.0
0.00
61
511
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
79
666
1.19
0.79
3.6
2.7
g/l
1.0
1.3
0.33
71
585
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
25
0.00
0.79
0.0
1.2
—
1.8
—
0
25
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
147
0.61
0.79
1.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
278
2556
1.10
0.78
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
460
0.78
0.76
1.3
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
15
99
1.52
0.75
1.1
1.3
nmol/l
1.1
1.1
—
10
75
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
18
125
1.44
0.72
1.4
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
76
1.58
0.71
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
172
1551
1.12
0.71
4.4
3.4
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
2.5
umol/l
41.0
44.6
—
5
19
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
26
1.93
0.70
1.2
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
418
3934
1.08
0.70
1.6
1.7
pmol/l
30769704.2
24428383.7
0.07
338
3234
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
58
1.55
0.69
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
9
143
0.63
0.69
2.4
2.1
ug/l
1.9
1.9
—
9
122
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
883
9132
0.94
0.69
2.6
2.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
9
146
0.61
0.69
2.3
2.0
ug/l
4.2
3.0
—
9
130
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
102
1.47
0.67
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
27
350
0.77
0.66
1.5
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
106
933
1.14
0.65
3.9
3.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
120
1.42
0.64
1.5
1.2
u/ml
0.3
1.1
—
10
59
(3025130) Human papilloma virus identified in Specimen
8
127
0.63
0.64
1.4
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
181
1.33
0.63
1.5
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
71
1.55
0.62
2.1
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
104
0.58
0.62
1.8
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
23
174
1.33
0.60
2.4
3.3
mg/l
26.9
30.5
0.10
18
134
(3002523) Influenza virus A Ag [Presence] in Specimen
24
183
1.32
0.59
1.5
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
52
1.54
0.59
1.1
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
8
52
1.54
0.59
2.5
1.7
pmol/l
18.1
15.1
—
8
42
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
72
1.53
0.59
1.2
1.2
iu/ml
275.9
223.2
0.20
11
72
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
47
396
1.19
0.53
3.2
1.3
mmol/l
3.7
3.8
0.64
42
369
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
214
1.27
0.52
1.3
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
132
0.68
0.52
1.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
1.3
1.5
ug/l
0.4
0.4
—
6
25
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
64
1.41
0.51
1.0
2.0
ug/l
15.6
144.2
—
9
55
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
21
270
0.78
0.51
1.9
1.9
pmol/l
196.4
212.5
0.39
21
252
(3023420) DNA double strand Ab [Units/volume] in Serum
21
162
1.30
0.50
1.2
1.3
—
29.4
—
0
8
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
67
1.50
0.49
1.6
1.5
umol/l
98.0
87.9
—
5
40
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
76
1.45
0.48
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
56
485
1.16
0.47
2.3
2.3
ug/min
94.4
101.1
0.09
34
291
(3023410) Appearance of Cerebral spinal fluid
24
191
1.26
0.46
5.7
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
24
191
1.26
0.46
3.2
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
69
609
1.14
0.45
3.1
2.5
g/l
35.1
37.6
2.49
63
535
(1617658) Protocol used for examination of sentinel lymph nodes
19
147
1.30
0.45
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
103
1.36
0.45
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
126
1155
1.10
0.44
3.1
3.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
51
1.37
0.44
1.3
1.2
%
100.1
107.2
—
7
44
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
403
0.84
0.42
3.1
3.2
nmol/l
0.9
0.8
0.36
27
314
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
47
406
1.16
0.42
2.0
1.6
—
—
—
0
0
(4198724)
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
267
1.20
0.42
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
70
1.43
0.41
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
19
239
0.79
0.41
1.3
1.2
nmol/l
0.7
0.7
0.04
19
224
(3016330) Potassium [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
105
1.34
0.41
1.6
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
39
334
1.17
0.39
1.2
1.2
u/ml
59.5
53.2
—
6
35
(3051593) INR in Capillary blood by Coagulation assay
7
101
0.69
0.39
11.7
13.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
71
1.41
0.39
1.7
1.2
%
—
75.2
—
0
10
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(4146454)
18
226
0.79
0.39
2.5
2.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1311
12920
1.04
0.39
5.5
4.2
mm/h
21.5
13.0
29.49
1211
11901
(3027008) Opiates [Presence] in Urine
21
258
0.81
0.38
1.3
1.5
—
—
—
0
0
(3036603) Volume of Urine
16
125
1.28
0.37
1.9
1.4
ml
2337.6
1807.2
—
10
22
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
80
0.62
0.35
1.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
80
0.62
0.35
1.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
80
0.62
0.35
1.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
80
0.62
0.35
1.0
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1866
18562
1.08
0.35
66.6
23.1
e9/l
239.1
246.7
4.03
1848
18067
(3011288) Drugs identified in Urine by Screen method
13
166
0.78
0.33
1.5
2.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
1866
18567
1.07
0.33
66.1
22.9
pg
30.8
30.4
7.60
1846
18277
(3024731) MCV [Entitic volume]
1866
18567
1.07
0.33
66.2
23.0
fl
93.4
91.5
34.90
1847
18279
(3009542) Hematocrit [Volume Fraction] of Blood
1506
14909
1.04
0.32
46.1
16.9
%
36.7
39.3
20.42
974
9958
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
220
0.82
0.32
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1866
18569
1.07
0.32
66.5
23.1
e12/l
4.1
4.5
133.45
1843
18012
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
53
1.32
0.30
1.0
1.9
ug/l
1.5
1.3
—
7
48
(3010813) Leukocytes [#/volume] in Blood
1866
18572
1.07
0.30
66.5
23.1
e9/l
7.4
6.7
2.40
1842
18016
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
43
381
1.13
0.30
1.3
1.6
nmol/l
0.8
0.8
0.05
38
308
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
129
1.24
0.30
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
196
0.81
0.30
1.0
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1866
18574
1.07
0.30
66.7
23.2
g/l
124.1
134.6
142.46
1845
18286
(3016879) Cocaine [Presence] in Urine
20
239
0.84
0.29
1.4
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
162
0.80
0.28
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
258
0.85
0.27
1.3
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
104
1.25
0.26
1.7
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
95
1.26
0.26
2.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
77
1.30
0.26
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1544
15561
0.97
0.26
8.1
4.8
mu/l
2.3
2.1
1.55
1440
14097
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
75
0.67
0.25
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
256
0.86
0.25
1.3
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
773
7596
1.03
0.24
2.0
2.0
pmol/l
87.5
94.2
3.85
489
3935
(3003327) Ova and parasites identified in Stool by Light microscopy
51
465
1.10
0.24
1.9
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
84
0.71
0.24
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
254
0.86
0.23
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
43
389
1.11
0.23
3.6
1.4
e6/l
7.8
36.4
1.08
34
296
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
389
1.11
0.23
3.7
1.5
e6/l
119.6
800.8
1.27
36
310
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
89
949
0.93
0.23
1.2
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
24
209
1.15
0.23
1.2
1.4
pmol/l
312.2
291.3
0.11
18
158
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
705
7173
0.97
0.22
2.5
2.2
nmol/l
75.6
78.7
2.15
650
6371
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
47
513
0.91
0.21
1.3
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
373.1
—
0
10
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
14
0.00
0.20
0.0
1.1
—
0.4
—
0
9
(3045414) Leukocytes [Presence] in Urine
75
799
0.94
0.20
1.8
1.9
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
111
0.81
0.20
1.2
1.6
—
74.1
—
0
8
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
50
1.20
0.19
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
109
1.19
0.18
2.0
2.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
68
0.73
0.17
1.0
1.1
—
547.5
—
0
20
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
87
0.80
0.14
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
87
0.80
0.14
3.0
1.3
nmol/l
216.7
136.3
—
7
87
(44813793)
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
8
100
0.80
0.13
1.1
1.7
—
10.4
—
0
6
(3047189) Immunofixation for 24 hour Urine
8
100
0.80
0.13
1.4
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
24
219
1.10
0.12
1.2
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
95
1.16
0.11
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
175
1707
1.03
0.11
1.6
1.7
%
1.6
1.5
0.19
145
1453
(3005570) Glucose [Moles/volume] in Urine
16
177
0.90
0.10
2.8
2.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
106
1.13
0.09
3.3
2.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
233
1.07
0.09
1.5
1.6
%
58.7
60.7
0.09
15
145
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.1
miu/ml
1285.7
1616.3
—
6
56
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
175
0.91
0.08
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
195
1986
0.98
0.08
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
282
2861
0.98
0.08
1.3
1.3
iu/ml
39.8
37.2
0.12
86
937
(3036071) Salmonella sp Ab [Titer] in Serum
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
305
3092
0.98
0.08
1.7
1.5
g/l
2.3
2.6
1.33
227
1852
(44806420)
5
60
0.83
0.08
1.4
2.6
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
74
0.81
0.07
1.5
2.0
nmol/l
17.8
6.4
—
6
62
(4024509)
16
174
0.92
0.07
1.9
1.6
—
—
—
0
0
(4027681)
7
84
0.83
0.07
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
8
91
0.88
0.06
1.0
1.1
—
12.2
—
0
25
(3045716) Anion gap in Serum or Plasma
8
90
0.89
0.06
1.5
2.8
mmol/l
8.3
9.7
—
8
72
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
93
0.86
0.06
1.6
1.2
u/l
1030.8
410.5
—
8
87
(3024928) Oxygen saturation in Venous blood
43
413
1.04
0.06
5.1
3.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
202
0.94
0.05
1.3
1.2
nmol/l
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
100
1.10
0.05
2.5
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
41
424
0.97
0.05
1.9
2.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
160
1.06
0.04
1.4
1.3
nmol/l
1.1
1.4
0.85
17
140
(3011397) Hemoglobin [Presence] in Urine by Test strip
407
4046
1.01
0.04
3.9
3.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
121
1.07
0.03
1.0
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
25
240
1.04
0.03
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
367
3687
0.99
0.02
4.7
4.2
kg/l
1.0
1.0
0.31
69
549
(3044927) Protein electrophoresis panel - Urine
21
218
0.96
0.02
1.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
243
1.03
0.01
1.7
2.5
mg/l
41.6
24.3
—
8
59
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
105
0.95
0.00
1.2
1.3
mmol/l
12.6
12.5
—
5
35
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
17
171
0.99
0.00
1.4
1.4
%
22.0
31.7
—
7
104
(3011648) Oxygen content in Venous blood
16
156
1.03
0.00
10.6
2.6
%
9.7
11.3
0.73
16
156
(3045424) Erythrocytes [Presence] in Urine
30
298
1.01
0.00
1.6
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
102
0.98
0.00
2.2
2.0
—
39.3
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
107
1.03
0.00
1.1
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
76
0.92
0.00
3.6
3.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
17.8
—
0
5
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.7
—
0
9
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.4
—
0
6
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
91.0
—
0
8
(3022689) Creatine [Moles/volume] in Urine
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
39
390
1.00
0.00
2.5
3.8
mg/l
28.4
26.6
0.09
25
236
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(4211845)
8
84
0.95
0.00
3.3
3.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.1
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.6
—
0
8
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).